anti-EGFP, mAB (rec.) (G3)

  • AG-27B-0007-C100100 µg INQ
Actions
Select size:

* Required Fields

Amount:
MSDS

Additional Information

Product Data
Synonyms Enhanced Green Fluorescent Protein
Properties
Clone G3
Isotype Human IgG2λ
Source/Host Purified from HEK 293 cell culture supernatant.
Immunogen/Antigen Enhanced Green Fluorescent Proteins (EGFP).
Application ELISA
Immunocytochemistry: (1:1000)
Immunoprecipitation: (1:200)
Specificity Recognizes EGFP, Enhanced Cyan Fluorescent Protein (ECFP) and Enhanced Yellow Fluorescent Protein (EYFP).
Purity ≥95% (SDS-PAGE)
Purity Detail Protein A-affinity purified.
Concentration 1mg/ml
Formulation Liquid. In PBS containing 10% glycerol and 0.02% sodium azide.
Other Product Data anti-EGFP, monoclonal antibody (recombinant) (G3) is composed of human variable regions (VH and VL) (λ-chain) of immunoglobulin fused to the human lgG2 Fc domain.
Product Type Recombinant Antibody
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice After opening, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 month after receipt when stored at +4°C. Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSDS Download Document Download

Product Description

anti-EGFP, monoclonal antibody (recombinant) (G3) is an antibody developed by antibody phage display technology using a human naive antibody gene library. These libraries consist of scFv (single chain fragment variable) composed of VH (variable domain of the human immunoglobulin heavy chain) and VL (variable domain of the human immunoglobulin light chain) connected by a polypeptide linker. The antibody fragments are displayed on the surface of filamentous bacteriophage (M13). This scFv was selected by affinity selection on antigen in a process termed panning. Multiple rounds of panning are performed to enrich for antigen-specific scFv-phage. Monoclonal antibodies are subsequently identified by screening after each round of selection. The selected monoclonal scFv is cloned into an appropriate vector containing a Fc portion of interest and then produced in mammalian cells to generate an IgG like scFv-Fc fusion protein.

Product References

  1. Fully in vitro selection of recombinant antibodies: S. Moutel, et al.; Biotech. J. 4, 38 (2009)
Schematic antibody structure.
Schematic antibody structure.
No reviews for this product yet.